SciELO - Scientific Electronic Library Online

vol.65 número1Avaliação da capacidade cardiorrespiratória em idosos com depressão maior e doença de AlzheimerTeste de Faux Pas em pacientes com esquizofrenia índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados




Links relacionados


Jornal Brasileiro de Psiquiatria

versão impressa ISSN 0047-2085versão On-line ISSN 1982-0208


SILVA, Luiz Fernando de Almeida Lima e et al. Assessing treatment response to prophylactic lithium use in patients with bipolar disorder. J. bras. psiquiatr. [online]. 2016, vol.65, n.1, pp.9-16. ISSN 0047-2085.


To identify potential clinical and epidemiological predictors of long-term response to lithium treatment.


A total of 40 adult outpatients followed in an university hospital, with confirmed diagnosis of bipolar disorder and with history of lithium use for at least a six months period, had their response to this medication assessed through the use of a standardized instrument. The ALDA scale is based on retrospective clinical data, in our study assessed through a thoroughly reviewed of the medical charts, and is used to evaluate the clinical improvement with the treatment (Criterion A), corrected by the acknowledgement of possible confounding factors, such as duration of the treatment, compliance and concomitant use of additional medications (Criterion B), in order to estimate the response that can be specifically attributable to lithium.


Our study found an inverse relation between the number of mood episodes with psychotic symptoms and lithium treatment outcome.


The results reinforce the hypothesis that lithium seems to be less efficacious in patients with bipolar disorder who present psychotic symptoms.

Palavras-chave : Bipolar disorder; psychotic disorders; lithium; treatment outcome; tobacco.

        · resumo em Português     · texto em Inglês     · Inglês ( pdf )